We are live on ! Find out more
JHMH

John Hancock Multifactor Healthcare ETF

Delisted

JHMH was delisted on the 24th of October, 2022.

21 hedge funds and large institutions have $53.3M invested in John Hancock Multifactor Healthcare ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

9% less funds holding

Funds holding: 2321 (-2)

18% less capital invested

Capital invested by funds: $64.9M → $53.3M (-$11.6M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

JHMH Hedge Fund Activity: Q2 2019 in Review

21 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q2 2019, worth a combined $53.3M — down 18% from $64.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of JHMH and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 8 added.

The largest buyer was Brinker Capital Investments, adding an estimated $712K. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $10.2M.

  • 21 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q2 2019, down from 23 in Q1 2019.
  • Funds reported $53.3M of John Hancock Multifactor Healthcare ETF stock for Q2 2019, down 18% quarter-over-quarter.
  • 3 funds opened new John Hancock Multifactor Healthcare ETF positions in Q2 2019 and 4 closed out, a net change of -1 holder.
  • The largest John Hancock Multifactor Healthcare ETF buyer in Q2 2019 was Brinker Capital Investments, an estimated $712K added.
  • The largest John Hancock Multifactor Healthcare ETF seller in Q2 2019 was Manulife (Manufacturers Life Insurance), an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2019.